RxDoctor Payments Data

Carla Ostronic

Physician Assistant · Osage Beach, MONPI 1780774091

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 93.1% of the total across 565 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 60 manufacturers, the largest accounting for just 12.1% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $3,802, more than ten times the $75 reported in 2021. Among physician assistant clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$11,510in general payments, 2019–2025

Across 565 payments — averaging $20.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • E.r. Squibb & Sons, L.L.C.$1K
  • Novartis$1K
  • Bristol Myers Squibb$725
  • Merck$591
  • Johnson & Johnson$498
  • plus $6K from 54 others

What the payments were for

  • Food & beverage$10,71493%
  • Education$7967%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie53$1,395
E.r. Squibb & Sons, L.L.C.51$1,142
Novartis61$1,037
Bristol Myers Squibb52$725
Merck31$591
Johnson & Johnson23$498
AstraZeneca22$497
Pfizer29$395
Exelixis Inc.6$394
Sanofi20$369
Incyte Corporation14$351
Gilead(2 entities)14$324
Stemline Therapeutics Inc.10$262
Regeneron Healthcare Solutions, Inc.10$225
Daiichi Sankyo Inc.10$215
Karyopharm Therapeutics Inc.9$206
GSK11$197
Bayer6$196
Eisai Inc.9$182
Lilly USA, LLC7$179
AVEO Pharmaceuticals, Inc.6$167
Genentech USA, Inc.8$137
Array Biopharma Inc9$126
Rigel Pharmaceuticals, Inc.11$118
Takeda Pharmaceuticals U.S.A., Inc.6$113
Boehringer Ingelheim6$112
Telix Pharmaceuticals2$106
Jazz Pharmaceuticals Inc.5$101
Genmab U.S., Inc.4$80
Tersera Therapeutics LLC3$78
Puma Biotechnology, Inc.4$72
Grifols USA, LLC4$71
Servier Pharmaceuticals LLC4$70
Mirati Therapeutics, Inc.3$57
Kyowa Kirin, Inc.3$54
EMD Serono, Inc.3$50
Myriad Genetic Laboratories, Inc.1$48
Taiho Oncology, Inc.3$45
Morphosys, US Inc.2$32
Amgen2$31
ADC Therapeutics America, Inc.2$31
Sobi, Inc2$31
Blueprint Medicines Corporation2$30
Dendreon Pharmaceuticals LLC2$29
Adaptive Biotechnologies Corporation2$27
Beigene USA, Inc.1$24
Ipsen Biopharmaceuticals, Inc1$24
Organon1$23
Agios Pharmaceuticals, Inc.1$22
Pharmacyclics LLC, An Abbvie Company1$22
Pharmaessentia USA Corporation1$21
Ambu Inc.1$20
Beone Medicines USA, Inc.1$18
Astellas Pharma US Inc1$18
Menarini Silicon Biosystems, Inc.1$17
Teva Pharmaceuticals USA, Inc.1$16
Sumitomo Pharma America, Inc.1$16
Springworks Therapeutics, Inc.1$16
Legend Biotech USA Inc.1$15
Blue Earth Diagnostics1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,510 in reported general payments places this provider in the 95th percentile of 1,380 physician assistant providers in Missouri.

See all physician assistant providers in Missouri

Medicare billing

Part B allowed, 2024
$40,403
Medicare patients
226
Services billed
639

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ImbruvicaIbrutinib17$278,343
IbrancePalbociclib12$191,422
Letrozole73$1,851
Ondansetron OdtOndansetron47$791
Hydroxyurea31$721
Prochlorperazine Maleate44$590
Dexamethasone20$388
Anastrozole25$233
Potassium Chloride23$144
Levothyroxine Sodium18$112
Levofloxacin17$101
Prednisone12$99
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav14$89
Acyclovir12$78
Omeprazole14$68

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Pharmacyclics LLC, An Abbvie CompanyImbruvica$22$278,34317 claims
PfizerIbrance$395$191,42212 claims
Teva Pharmaceuticals USA, Inc.Acyclovir$16$7812 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,380 physician assistant providers in Missouri.

Other physician assistant in Osage Beach

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →